Phillips Financial Management’s iShares MSCI Emerging Markets ETF EEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.66K Hold
82
﹤0.01% 277
2025
Q4
$4.49K Buy
+82
New +$4.46K ﹤0.01% 299
2025
Q3
Sell
-25
Closed -$1.21K 306
2025
Q2
$1.21K Buy
+25
New +$1.12K ﹤0.01% 278
2025
Q1
Sell
-910
Closed -$38.1K 260
2024
Q4
$38.1K Hold
910
﹤0.01% 216
2024
Q3
$41.7K Hold
910
﹤0.01% 222
2024
Q2
$38.8K Hold
910
﹤0.01% 220
2024
Q1
$37.4K Hold
910
﹤0.01% 215
2023
Q4
$36.6K Hold
910
﹤0.01% 202
2023
Q3
$34.5K Hold
910
﹤0.01% 202
2023
Q2
$36K Sell
910
-510
-36% -$20.1K ﹤0.01% 197
2023
Q1
$56K Hold
1,420
0.01% 189
2022
Q4
$53.8K Buy
1,420
+300
+27% +$11.1K 0.01% 177
2022
Q3
$39K Buy
+1,120
New +$43.7K ﹤0.01% 177

Other funds holding EEM

Phillips Financial Management's EEM Position: Q1 2026 in Review

Phillips Financial Management held its iShares MSCI Emerging Markets ETF (EEM) position steady in Q1 2026 at 82 shares worth $4.66K. The position accounts for ﹤0.01% of the portfolio, ranked #277.

Phillips Financial Management first reported a position in EEM in Q3 2022 and has held it in 13 quarters since. The position peaked at $56K in Q1 2023. 1,608 funds tracked by Wall St. Rank hold EEM as of Q1 2026.

  • Phillips Financial Management held 82 shares of iShares MSCI Emerging Markets ETF worth $4.66K as of Q1 2026.
  • Phillips Financial Management left its iShares MSCI Emerging Markets ETF share count unchanged in Q1 2026.
  • iShares MSCI Emerging Markets ETF made up ﹤0.01% of Phillips Financial Management's portfolio in Q1 2026, its #277 holding.
  • Phillips Financial Management first reported a position in iShares MSCI Emerging Markets ETF in Q3 2022 and has held it in 13 quarters since.
  • Phillips Financial Management's iShares MSCI Emerging Markets ETF position peaked at $56K in Q1 2023.
  • 1,608 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ETF as of Q1 2026.

Based on Phillips Financial Management's 13F filing for Q1 2026, filed 16 Apr 2026.